 University of California, San Diego researchers edited a gene called CISH from the immune systems natural killer NK cells, freeing up the signaling of cytokinesmolecules that direct immune cells to destroy invaders. The edited NK cells cleared leukemia in mouse models and could prove promising as an off-the-shelf cell therapy for some cancers, the researchers said. 